1st Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Firm
Client
Income
—
Expenses
$1,080,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

-H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations -Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines

LobbyistCovered position, as disclosed
GRANT BARBOSA —
CHRIS FRECH —
KATHERINE GETTY New —
JILL HAMAKER —

Contacted: SENATE; Health Resources & Services Administration (HRSA); Office of the Vice President of the United States; White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 3548 (116th), H.R. 6074 (116th)

Budget/Appropriations BUD

-H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations -Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines

LobbyistCovered position, as disclosed
GRANT BARBOSA —
KATHERINE GETTY —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Office of the Vice President of the United States; Health Resources & Services Administration (HRSA)

Bills named: S. 3548 (116th), H.R. 6074 (116th)

Homeland Security HOM

-H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations -Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines

LobbyistCovered position, as disclosed
GRANT BARBOSA —
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Health Resources & Services Administration (HRSA)

Bills named: S. 3548 (116th), H.R. 6074 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.